425 related articles for article (PubMed ID: 9036064)
1. [13-cis retinoic acid and interferon-alfa-2a as palliative therapy in pretreated, recurrent squamous epithelial carcinoma of the cervix uteri and vulva].
Römisch M; Meier W; Kimmig R; Hepp H
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):520-4. PubMed ID: 9036064
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of 32 cervico-uterine cancer patients with 13-cis-retinoic acid and interferon alpha].
Paredes Espinoza M; Lippman SM; Kavanagh JJ; Delgadillo Madrueño F; Paredes Casillas P; Bañuelos Acosta O; Alvarez Márquez V; Buenrostro Ahued MA; de Alba Ayala I; Arias Castro G
Rev Invest Clin; 1994; 46(2):105-11. PubMed ID: 8052740
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix.
Hallum AV; Alberts DS; Lippman SM; Inclan L; Shamdas GJ; Childers JM; Surwit EA; Modiano M; Hatch KD
Gynecol Oncol; 1995 Mar; 56(3):382-6. PubMed ID: 7705672
[TBL] [Abstract][Full Text] [Related]
4. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: novel bioadjuvant phase II trial.
Shin DM; Khuri FR; Murphy B; Garden AS; Clayman G; Francisco M; Liu D; Glisson BS; Ginsberg L; Papadimitrakopoulou V; Myers J; Morrison W; Gillenwater A; Ang KK; Lippman SM; Goepfert H; Hong WK
J Clin Oncol; 2001 Jun; 19(12):3010-7. PubMed ID: 11408495
[TBL] [Abstract][Full Text] [Related]
5. Phase 2 trial of paclitaxel, 13-cis retinoic acid, and interferon alfa-2b in the treatment of advanced stage or recurrent cervical cancer.
Song M; DiPaola RS; Cracchiolo BM; Gibbon DG; Hellmann M; Nieves-Neira W; Vaidya A; Wagreich AR; Shih WJ; Rodriguez-Rodriguez L
Int J Gynecol Cancer; 2014 Nov; 24(9):1636-41. PubMed ID: 25304678
[TBL] [Abstract][Full Text] [Related]
6. Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project.
Carson LF; Twiggs LB; Adcock LL; Prem KA; Potish RA
J Reprod Med; 1990 Nov; 35(11):1029-32. PubMed ID: 2277364
[TBL] [Abstract][Full Text] [Related]
7. 13-cis-retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix.
Lippman SM; Kavanagh JJ; Paredes-Espinoza M; Delgadillo-Madrueño F; Paredes-Casillas P; Hong WK; Holdener E; Krakoff IH
J Natl Cancer Inst; 1992 Feb; 84(4):241-5. PubMed ID: 1734085
[TBL] [Abstract][Full Text] [Related]
8. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study.
Lupi G; Raspagliesi F; Zucali R; Fontanelli R; Paladini D; Kenda R; di Re F
Cancer; 1996 Apr; 77(8):1472-8. PubMed ID: 8608531
[TBL] [Abstract][Full Text] [Related]
9. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).
Skeel RT; Huang J; Manola J; Wilding G; Dreicer R; Walker P; Muggia F; Crawford ED; Dutcher JP; Loehrer PJ
Cancer Invest; 2003; 21(1):41-6. PubMed ID: 12643008
[TBL] [Abstract][Full Text] [Related]
11. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
[TBL] [Abstract][Full Text] [Related]
12. Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.
Eisenhauer EA; Lippman SM; Kavanagh JJ; Parades-Espinoza M; Arnold A; Hong WK; Massimini G; Schleuniger U; Bollag W; Holdener EE
Leukemia; 1994 Oct; 8(10):1622-5. PubMed ID: 7934156
[TBL] [Abstract][Full Text] [Related]
13. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.
Lippman SM; Parkinson DR; Itri LM; Weber RS; Schantz SP; Ota DM; Schusterman MA; Krakoff IH; Gutterman JU; Hong WK
J Natl Cancer Inst; 1992 Feb; 84(4):235-41. PubMed ID: 1734084
[TBL] [Abstract][Full Text] [Related]
14. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases.
Piura B; Masotina A; Murdoch J; Lopes A; Morgan P; Monaghan J
Gynecol Oncol; 1993 Feb; 48(2):189-95. PubMed ID: 8428690
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study.
Park TK; Lee JP; Kim SN; Choi SM; Kudelka AP; Kavanagh JJ
Eur J Gynaecol Oncol; 1998; 19(1):35-8. PubMed ID: 9476056
[TBL] [Abstract][Full Text] [Related]
16. Groin recurrence in carcinoma of the vulva: management and outcome.
Cormio G; Loizzi V; Carriero C; Cazzolla A; Putignano G; Selvaggi L
Eur J Cancer Care (Engl); 2010 May; 19(3):302-7. PubMed ID: 19832900
[TBL] [Abstract][Full Text] [Related]
17. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon.
Dunst J; Hänsgen G; Lautenschläger C; Füchsel G; Becker A
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):367-73. PubMed ID: 10030263
[TBL] [Abstract][Full Text] [Related]
18. A 2-week pretreatment with 13-cis-retinoic acid + interferon-alpha-2a prior to definitive radiation improves tumor tissue oxygenation in cervical cancers.
Dunst J; Hänsgen G; Krause U; Füchsel G; Köhler U; Becker A
Strahlenther Onkol; 1998 Nov; 174(11):571-4. PubMed ID: 9830438
[TBL] [Abstract][Full Text] [Related]
19. Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study.
Nikolaou AC; Fountzilas G; Daniilidis I
J Laryngol Otol; 1996 Sep; 110(9):857-61. PubMed ID: 8949297
[TBL] [Abstract][Full Text] [Related]
20. Midline involvement as a risk factor for vulvar cancer recurrence.
Stankevica J; Macuks R; Baidekalna I; Donina S
Asian Pac J Cancer Prev; 2012; 13(10):5237-40. PubMed ID: 23244142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
